Meta-analysis of surgery in advanced ovarian carcinoma: Ismaximum cytoreductive surgery an independent determinant of prognosis?
- 1 February 1992
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 166 (2) , 504-511
- https://doi.org/10.1016/0002-9378(92)91658-w
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The treatment of advanced ovarian carcinoma (I): Clinical variables associated with prognosisGynecologic Oncology, 1988
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- Prognostic factors in malignant epithelial ovarian tumorsGynecologic Oncology, 1983
- Surgery for common epithelial tumors of the ovaryCancer, 1981
- Review of ovarian cancer at the University of Texas Systems Cancer Center, M. D. Anderson Hospital and Tumor InstituteAmerican Journal of Obstetrics and Gynecology, 1979
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- Intensive Surgical and Chemotherapeutic Management of Advanced Ovarian CancerSurgical Clinics of North America, 1978
- Advanced ovarian cancer: Primary treatment with surgery, radiotherapy, and chemotherapyCancer, 1972
- The changing prognosis and treatment in cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1968
- Variations in survival among patients with carcinoma of the ovary.Analysis of 253 cases according to histologic type, anatomical stage and method of treatmentCancer, 1967